1. Home
  2. GOVX vs MITQ Comparison

GOVX vs MITQ Comparison

Compare GOVX & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

HOLD

Current Price

$1.70

Market Cap

4.6M

Sector

Health Care

ML Signal

HOLD

Logo Moving iMage Technologies Inc.

MITQ

Moving iMage Technologies Inc.

HOLD

Current Price

$0.64

Market Cap

6.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOVX
MITQ
Founded
2001
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
6.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GOVX
MITQ
Price
$1.70
$0.64
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$103.00
N/A
AVG Volume (30 Days)
148.5K
25.2K
Earning Date
03-26-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,353,560.00
$18,477,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.52
N/A
52 Week Low
$2.28
$0.50
52 Week High
$47.13
$1.66

Technical Indicators

Market Signals
Indicator
GOVX
MITQ
Relative Strength Index (RSI) 41.24 39.33
Support Level $2.51 $0.62
Resistance Level $2.76 $0.79
Average True Range (ATR) 0.25 0.06
MACD -0.17 -0.01
Stochastic Oscillator 2.69 18.02

Price Performance

Historical Comparison
GOVX
MITQ

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: